These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38333520)

  • 1. Approval status of essential therapeutic drugs for systemic sclerosis versus that of drugs for rheumatoid arthritis.
    Moon KW; Hwang SH; Yun J; Lee EB
    J Scleroderma Relat Disord; 2024 Feb; 9(1):23-28. PubMed ID: 38333520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Sclerosis and Pulmonary Disease.
    Ngo K
    Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries.
    Zhang Y; Hueser HC; Hernandez I
    J Manag Care Spec Pharm; 2017 Feb; 23(2):247-254. PubMed ID: 28125371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications.
    Kwon HY; Kim H; Godman B
    Front Pharmacol; 2018; 9():938. PubMed ID: 30233363
    [No Abstract]   [Full Text] [Related]  

  • 5. MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study.
    Hughes M; Di Donato S; Gjeloshi K; Abignano G; Danzo F; Lettieri G; De Lorenzis E; Bertham D; O'Connor P; Kubassova O; Dehmeshki J; Del Galdo F
    Lancet Rheumatol; 2023 Oct; 5(10):e611-e621. PubMed ID: 38251485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease.
    Hafner J; Schneider E; Burg G; Cassina PC
    J Vasc Surg; 2000 Aug; 32(2):322-9. PubMed ID: 10917993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Raynaud's phenomenon in systemic sclerosis-a practical approach.
    Fernández-Codina A; Cañas-Ruano E; Pope JE
    J Scleroderma Relat Disord; 2019 Jun; 4(2):102-110. PubMed ID: 35382396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
    Silva C; Solanki KK; White DHN
    Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study.
    Lee YC; Fox RS; Kwakkenbos L; Levis B; Carrier ME; Welling J; Sauvé M; Mouthon L; Benedetti A; Bartlett SJ; Varga J; Thombs BD;
    Lancet Rheumatol; 2021 Dec; 3(12):e844-e854. PubMed ID: 38287631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.
    Shaw DL; Dhruva SS; Ross JS
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1230-1238. PubMed ID: 30479199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatoid arthritis, progressive systemic sclerosis without skin involvement and mixed collagen disease in a family. Clinical description of a mother and her 3 adult children--studies of HLA antigens and review of the literature].
    Stockmann G; Franke M; Kasulke D
    Z Rheumatol; 1986; 45(1):16-25. PubMed ID: 3705774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval.
    Bertele' V; Assisi A; Di Muzio V; Renzo D; Garattini S
    Eur J Clin Pharmacol; 2007 Sep; 63(9):879-89. PubMed ID: 17646975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis.
    Jinnin M; Ihn H; Yamane K; Asano Y; Yazawa N; Tamaki K
    Clin Exp Rheumatol; 2003; 21(1):91-4. PubMed ID: 12673896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.
    Tikhonova IA; Yang H; Bello S; Salmon A; Robinson S; Hemami MR; Dodman S; Kharechko A; Haigh RC; Jani M; McDonald TJ; Hoyle M
    Health Technol Assess; 2021 Feb; 25(8):1-248. PubMed ID: 33555998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis.
    Di Matteo A; Bathon JM; Emery P
    Lancet; 2023 Nov; 402(10416):2019-2033. PubMed ID: 38240831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with bosentan and sildenafil for refractory digital ulcers and Raynaud's phenomenon in a 30-year-old woman with systemic sclerosis: Case report and literature review.
    Rademacher JG; Wincup C; Tampe B; Korsten P
    J Scleroderma Relat Disord; 2020 Jun; 5(2):159-164. PubMed ID: 35382024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.